MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

Search

Cigna Corp

Slēgts

331.9 0.36

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

326.27

Max

332.17

Galvenie mērījumi

By Trading Economics

Ienākumi

711M

1.5B

Pārdošana

2B

66B

P/E

Sektora vidējais

27.168

63.778

EPS

6.64

Dividenžu ienesīgums

1.84

Peļņas marža

2.337

Darbinieki

71,295

EBITDA

799M

3B

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt (spēcīgs)

Prognoze 12 mēnešiem

+10.64% upside

Dividendes

By Dow Jones

Dividenžu ienesīgums

Sektora vidējais

1.84%

2.39%

Nākamie ieņēmumi

2025. g. 2. maijs

Nākamais Ex dividenžu datums

2025. g. 2. jūn.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

6.8B

89B

Iepriekšējā atvēršanas cena

331.54

Iepriekšējā slēgšanas cena

331.9

Tehniskais rādītājs

By Trading Central

Pārliecība

Strong Bullish Evidence

Cigna Corp Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 2. apr. 18:20 UTC

Top Ziņas

Trump's Move to Dump FTC's Democratic Members Leaves Insulin Case in Limbo -- WSJ

2025. g. 12. febr. 15:24 UTC

Top Ziņas
Peļņas

CVS Health Stock Jumps on Earnings Beat and Solid Guidance. 'Phew!' Says One Analyst. -- Barrons.com

2025. g. 12. febr. 13:58 UTC

Top Ziņas
Peļņas

CVS Health Stock Jumps on Earnings Beat and Solid Guidance. 'Phew!' Says One Analyst. -- Barrons.com

2025. g. 12. febr. 12:16 UTC

Top Ziņas
Peļņas

CVS Health Stock Jumps on Earnings Beat and Solid Guidance -- Barrons.com

2025. g. 12. febr. 11:55 UTC

Peļņas

CVS Health Stock Jumps on Earnings Beat and Solid Guidance -- Barrons.com

2025. g. 11. febr. 21:30 UTC

Top Ziņas

CVS Health Stock Is Making a Comeback. Earnings Are the Next Hurdle. -- Barrons.com

2025. g. 11. febr. 17:32 UTC

Top Ziņas

Humana Stock Slides Despite Solid Quarter Amid Weak Forecast -- Barrons.com

2025. g. 11. febr. 17:05 UTC

Top Ziņas

Humana Stock Is Rising. Its Quarter Was Better Than Feared. -- Barrons.com

2025. g. 30. janv. 14:51 UTC

Peļņas

Cigna Stock Dives After Earnings. Here's What Went Wrong. -- Barrons.com

2025. g. 30. janv. 14:46 UTC

Peļņas

Cigna Stock Dives After Earnings. Here's What Went Wrong. -- Barrons.com

2025. g. 30. janv. 12:29 UTC

Peļņas

Cigna Stock Dives After Earnings. Here's What Went Wrong. -- Barrons.com

2025. g. 30. janv. 11:04 UTC

Peļņas

Cigna Earnings Fall Short of Projections, Hit by Rising Costs -- WSJ

2025. g. 30. janv. 11:00 UTC

Peļņas

Cigna Group: Taking Corrective Actions to Address Near-Term Pressures and Taking Steps to Further AdvaLong-Term Growth Strategy >CI

2025. g. 30. janv. 11:00 UTC

Peļņas

Cigna Group Sees 2025 Adj. Income From Operations at Least $7.9B, or at Least $29.50/Shr >CI

2025. g. 30. janv. 11:00 UTC

Peļņas

Cigna Group Sees 2025 Adj. Revenue of at Least $252B >CI

2025. g. 30. janv. 11:00 UTC

Peļņas

Cigna Group: Previously Announced Divestiture of Medicare Businesses to HCSC Expected to Close in 1Q of 2025 >CI

2025. g. 30. janv. 11:00 UTC

Peļņas

Cigna Group Sees 2025 Capital Spending About $1.4B >CI

2025. g. 30. janv. 11:00 UTC

Peļņas

Cigna Group Sees 2025 Cash Flow From Operations of About $10B >CI

2025. g. 30. janv. 11:00 UTC

Peļņas

Cigna Group Raises Qtrly Dividend to $1.51 Vs. $1.40 >CI

2025. g. 30. janv. 11:00 UTC

Peļņas

Cigna Group: Total Customer Relationships at Dec. 31, 2024, Rose 11% From Dec. 31, 2023, to 182.2M >CI

2025. g. 30. janv. 11:00 UTC

Peļņas

Cigna Group 4Q Revenue Growth Primarily Driven by Significant Growth in Evernorth Health Services >CI

2025. g. 30. janv. 11:00 UTC

Peļņas

Cigna Group: Higher Medical Costs in Stop Loss Product Affected 4Q Earnings >CI

2025. g. 30. janv. 11:00 UTC

Peļņas

Cigna Group: Bd Approves Increase of $6B in Incremental Share Repurchase Authorization, Bringing Total Authorization to $10.3B >CI

2025. g. 30. janv. 11:00 UTC

Peļņas

Cigna Group: Total Pharmacy Customers at Dec. 31, 2024, Rose 20% From Dec. 31, 2023, to 118.3M >CI

2025. g. 30. janv. 11:00 UTC

Peļņas

Cigna Group: Total Medical Customers at Dec. 31, 2024, Were 19.1M >CI

2025. g. 30. janv. 11:00 UTC

Peļņas

Cigna Group 4Q Adj EPS $6.64 >CI

2025. g. 30. janv. 11:00 UTC

Peļņas

Cigna Group 4Q Rev $65.65B >CI

2025. g. 30. janv. 11:00 UTC

Peļņas

Cigna Group 4Q EPS $5.13 >CI

2025. g. 30. janv. 11:00 UTC

Peļņas

The Cigna Group Reports Fourth Quarter And Full Year 2024 Results, Establishes 2025 Outlook And Increases Dividend >CI

2025. g. 30. janv. 11:00 UTC

Peļņas

Cigna Group 4Q Rev $65.65B >CI

Salīdzinājums

Cenas izmaiņa

Cigna Corp Prognoze

Cenas mērķis

By TipRanks

10.64% augšup

Prognoze 12 mēnešiem

Vidējais 366.22 USD  10.64%

Augstākais 420 USD

Zemākais 323 USD

Pamatojoties uz 19 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Cigna Corp — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

19 ratings

16

Pirkt

3

Turēt

0

Pārdot

Tehniskais rādītājs

By Trading Central

320.83 / 333.25Atbalsts un pretestība

Īstermiņā

Strong Bullish Evidence

Vidējā termiņā

Bullish Evidence

Ilgtermiņā

Bullish Evidence

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Cigna Corp

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. In addition, it offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. The company distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The Cigna Group was founded in 1792 and is headquartered in Bloomfield, Connecticut.